Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. May 26, 2024; 16(5): 217-220
Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.217
Congenital heart “Challenges” in Down syndrome
Maria Drakopoulou, Panayotis K Vlachakis, Costas Tsioufis, Dimitris Tousoulis
Maria Drakopoulou, Panayotis K Vlachakis, Costas Tsioufis, Dimitris Tousoulis, Department of First Cardiology, Hippokration General Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece
Author contributions: Drakopoulou M, Vlachakis PK for literature review; Drakopoulou M, Vlachakis PK, Tsioufis C, Tousoulis D for writing, original manuscript preparation. All authors have read and agreed to be published version of the manuscript.
Conflict-of-interest statement: The authors have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maria Drakopoulou, FESC, MD, MSc, PhD, Lecturer, Department of First Cardiology, Hippokration General Hospital, Athens Medical School, National and Kapodistrian University of Athens, 114 Vasilissis Sophia Avenue, Athens 11527, Greece. mdrakopoulou@hotmail.com
Received: November 30, 2023
Revised: April 18, 2024
Accepted: May 13, 2024
Published online: May 26, 2024
Processing time: 175 Days and 1.9 Hours
Core Tip

Core Tip: Addressing the health challenges of individuals with Down syndrome (DS) poses intricate challenges, with congenital heart disease (CHD) being notably prevalent. The complexity of managing DS and CHD is heightened by diagnostic delays and difficulties in symptom assessment due to intellectual disabilities. Incorporating this unique population into comprehensive studies and randomized trials, with careful consideration of informed consent and a multidisciplinary research framework, is crucial.